BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11310652)

  • 1. Coronary artery disease prevention: what's different for women?
    Bedinghaus J; Leshan L; Diehr S
    Am Fam Physician; 2001 Apr; 63(7):1393-400, 1405-6. PubMed ID: 11310652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of coronary heart disease in elderly patients.
    Hanna IR; Wenger NK
    Am Fam Physician; 2005 Jun; 71(12):2289-96. PubMed ID: 15999866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of CHD: nine ways to reduce risk.
    Havranek EP
    Am Fam Physician; 1999 Mar; 59(6):1455-63, 1466. PubMed ID: 10193589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and secondary prevention of ischemic heart disease.
    Bittner V
    Curr Opin Cardiol; 1994 Jul; 9(4):417-27. PubMed ID: 7919586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease and prevention of heart failure.
    Klein L; Gheorghiade M
    Med Clin North Am; 2004 Sep; 88(5):1209-35. PubMed ID: 15331314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of primary and secondary prevention on morbidity and mortality of ischemic cardiopathy].
    Posadas-Romero C
    Arch Cardiol Mex; 2002; 72 Suppl 1():S167-70. PubMed ID: 12001839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we screen asymptomatic individuals for coronary artery disease or implement universal lipid-lowering therapy?
    Thomas GS
    Cardiol Rev; 2005; 13(1):40-5. PubMed ID: 15596028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention of coronary heart disease].
    von Schacky C
    MMW Fortschr Med; 2003 Mar; 145(13):28, 30, 32-3. PubMed ID: 15101529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
    Vitale C; Miceli M; Rosano GM
    Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic heart disease in women and the role of hormone therapy.
    Raza JA; Reinhart RA; Movahed A
    Int J Cardiol; 2004 Jul; 96(1):7-19. PubMed ID: 15203255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease and women: applying the guidelines for risk factor management.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():5A-10A. PubMed ID: 10653924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of coronary heart disease: a nonhormonal approach.
    Lewis V; Hoeger K
    Semin Reprod Med; 2005 May; 23(2):157-66. PubMed ID: 15852201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.